Global Payments
The share prices for Global Payments experienced a 9.2% dip in the premarket trading. The payments technology company experienced the dip even when sharing its earnings results that were better than the estimations.
For the first quarter of 2022, Global Payments reported that the earnings it generated were $2.07 per share. The estimations that the analysts had made for the respective quarter were $2.04 per share.
This goes to show that Global Payments successfully beat the earnings estimations set by the Refinitiv analysts by 3 cents. Global Payments also reported that the revenue it generated was higher than the expectations set by the analysts.
The payments technology company also shared its guidance for the entire year. For the rest of the year, Global Payments upgraded the revenue estimations.
Vertex Pharmaceuticals
The share prices for Vertex Pharmaceuticals experienced a 4.1% dip in the premarket trading. The share prices for Food and Drug Administration Company experienced the dip after it made an announcement about its Vertex treatment.
According to sources, Vertex Pharmaceuticals has announced the hold of its Vertex treatment. The particular treatment is used for type 1 diabetes.
The company revealed that it doesn’t have much information and data surrounding the product’s support dose escalation.
Moderna
Moderna has reportedly experienced a 5.7% surge in its share prices in the premarket trading. The share prices of the drugmaker experienced the rise after providing an update about the COVID-19 vaccine. The executives revealed that soon, they will have readied the COVID-19 vaccine for children who are under the age of 6.
Once readied, the documentation will be submitted at the Food and Drug Administration for review purposes. The officials at Moderna confirmed that they had submitted the review request last week.
Moody’s Corp
The share prices of Moody’s Corp have experienced a 4.9% dip in the premarket trading. The risk assessment firm experienced a plummet after sharing its earnings guidance for the rest of the year.
According to the executives at Moody’s Corp, the earnings guidance they shared ranged from $10.75 per share to $11.25 per share. Previously, the guidance Moody’s Corp’s executives had set for the same period ranged from $12.40 per share to $12.90 per share.
On the other hand, the analysts have predicted that Moody’s Corp may be able to achieve earnings worth $11.92 per share.
Align Technology
The share prices of Align Technology have experienced a 6.5% surge in its share prices in the premarket trading. The share prices for medical device maker experienced the rise after making an announcement about its repurchase program.
Align Technology announced that going forward, it will proceed with its stocks repurchase program. During the program, Align Technology will repurchase $200 million worth of its stocks.
